Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Differential Induction of IFN-α and Modulation of CD112 and CD54 Expression Govern the Magnitude of NK Cell IFN-γ Response to Influenza A Viruses.

Kronstad LM, Seiler C, Vergara R, Holmes SP, Blish CA.

J Immunol. 2018 Oct 1;201(7):2117-2131. doi: 10.4049/jimmunol.1800161. Epub 2018 Aug 24.

PMID:
30143589
2.

Maintaining a Robust Pipeline of Future Physician-Scientists.

Blish CA.

J Infect Dis. 2018 Aug 14;218(suppl_1):S40-S43. doi: 10.1093/infdis/jiy093.

PMID:
30124975
3.

Diversification of human NK cells: Lessons from deep profiling.

Wilk AJ, Blish CA.

J Leukoc Biol. 2018 Apr;103(4):629-641. doi: 10.1002/JLB.6RI0917-390R. Epub 2018 Jan 19. Review.

PMID:
29350874
4.

Humanized mouse model supports development, function, and tissue residency of human natural killer cells.

Herndler-Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, Strowig T, de Zoete MR, Palm NW, Chen J, Blish CA, Frleta D, Gurer C, Macdonald LE, Murphy AJ, Yancopoulos GD, Montgomery RR, Flavell RA.

Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9626-E9634. doi: 10.1073/pnas.1705301114. Epub 2017 Oct 25.

5.

Redefining Memory: Building the Case for Adaptive NK Cells.

Paust S, Blish CA, Reeves RK.

J Virol. 2017 Sep 27;91(20). pii: e00169-17. doi: 10.1128/JVI.00169-17. Print 2017 Oct 15. Review.

6.

The natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infection.

Yao Y, Strauss-Albee DM, Zhou JQ, Malawista A, Garcia MN, Murray KO, Blish CA, Montgomery RR.

PLoS One. 2017 Feb 24;12(2):e0172625. doi: 10.1371/journal.pone.0172625. eCollection 2017.

7.

NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus.

Hatton O, Strauss-Albee DM, Zhao NQ, Haggadone MD, Pelpola JS, Krams SM, Martinez OM, Blish CA.

Front Immunol. 2016 Dec 15;7:607. doi: 10.3389/fimmu.2016.00607. eCollection 2016.

8.

Mass Cytometry Analytical Approaches Reveal Cytokine-Induced Changes in Natural Killer Cells.

Vendrame E, Fukuyama J, Strauss-Albee DM, Holmes S, Blish CA.

Cytometry B Clin Cytom. 2017 Jan;92(1):57-67. doi: 10.1002/cyto.b.21500.

9.

The newborn human NK cell repertoire is phenotypically formed but functionally reduced.

Strauss-Albee DM, Liang EC, Ranganath T, Aziz N, Blish CA.

Cytometry B Clin Cytom. 2017 Jan;92(1):33-41. doi: 10.1002/cyto.b.21485. Epub 2016 Nov 8.

10.

Zika Virus Infection Induces Cranial Neural Crest Cells to Produce Cytokines at Levels Detrimental for Neurogenesis.

Bayless NL, Greenberg RS, Swigut T, Wysocka J, Blish CA.

Cell Host Microbe. 2016 Oct 12;20(4):423-428. doi: 10.1016/j.chom.2016.09.006. Epub 2016 Sep 29.

11.

Increased Proinflammatory Responses of Monocytes and Plasmacytoid Dendritic Cells to Influenza A Virus Infection During Pregnancy.

Le Gars M, Kay AW, Bayless NL, Aziz N, Dekker CL, Swan GE, Davis MM, Blish CA.

J Infect Dis. 2016 Dec 1;214(11):1666-1671. Epub 2016 Sep 21.

12.
13.

Application of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer Cells.

Kay AW, Strauss-Albee DM, Blish CA.

Methods Mol Biol. 2016;1441:13-26. doi: 10.1007/978-1-4939-3684-7_2.

14.

Human NK Cell Diversity in Viral Infection: Ramifications of Ramification.

Strauss-Albee DM, Blish CA.

Front Immunol. 2016 Mar 3;7:66. doi: 10.3389/fimmu.2016.00066. eCollection 2016. Review.

15.

Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility.

Strauss-Albee DM, Fukuyama J, Liang EC, Yao Y, Jarrell JA, Drake AL, Kinuthia J, Montgomery RR, John-Stewart G, Holmes S, Blish CA.

Sci Transl Med. 2015 Jul 22;7(297):297ra115. doi: 10.1126/scitranslmed.aac5722.

16.

Immunogenicity and Clinical Efficacy of Influenza Vaccination in Pregnancy.

Kay AW, Blish CA.

Front Immunol. 2015 Jun 4;6:289. doi: 10.3389/fimmu.2015.00289. eCollection 2015. Review.

17.

Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells.

Grow EJ, Flynn RA, Chavez SL, Bayless NL, Wossidlo M, Wesche DJ, Martin L, Ware CB, Blish CA, Chang HY, Pera RA, Wysocka J.

Nature. 2015 Jun 11;522(7555):221-5. doi: 10.1038/nature14308. Epub 2015 Apr 20.

18.

Pregnancy Does Not Attenuate the Antibody or Plasmablast Response to Inactivated Influenza Vaccine.

Kay AW, Bayless NL, Fukuyama J, Aziz N, Dekker CL, Mackey S, Swan GE, Davis MM, Blish CA.

J Infect Dis. 2015 Sep 15;212(6):861-70. doi: 10.1093/infdis/jiv138. Epub 2015 Mar 4.

19.

Coordinated regulation of NK receptor expression in the maturing human immune system.

Strauss-Albee DM, Horowitz A, Parham P, Blish CA.

J Immunol. 2014 Nov 15;193(10):4871-9. doi: 10.4049/jimmunol.1401821. Epub 2014 Oct 6.

20.

Enhanced natural killer-cell and T-cell responses to influenza A virus during pregnancy.

Kay AW, Fukuyama J, Aziz N, Dekker CL, Mackey S, Swan GE, Davis MM, Holmes S, Blish CA.

Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14506-11. doi: 10.1073/pnas.1416569111. Epub 2014 Sep 22.

21.

Delayed BCG vaccination--time to take a shot.

Kay AW, Blish CA.

J Infect Dis. 2015 Feb 1;211(3):335-7. doi: 10.1093/infdis/jiu435. Epub 2014 Aug 8. No abstract available.

PMID:
25108029
22.

Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adults.

Liang EC, Sceats L, Bayless NL, Strauss-Albee DM, Kubo J, Grant PM, Furman D, Desai M, Katzenstein DA, Davis MM, Zolopa AR, Blish CA.

J Virol. 2014 Aug;88(15):8629-39. doi: 10.1128/JVI.01257-14. Epub 2014 May 21.

23.

Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.

Blish CA, Dogan OC, Jaoko W, McClelland RS, Mandaliya K, Odem-Davis K, Richardson BA, Overbaugh J.

J Virol. 2014 May;88(10):5894-9. doi: 10.1128/JVI.00187-14. Epub 2014 Mar 12.

24.

Systemic cytokine levels show limited correlation with risk of HIV-1 acquisition.

Lehman DA, Ronen K, Blish CA, Baeten JM, Jalalian-Lechak Z, Jaoko W, Mandaliya K, Richardson BA, McClelland RS, Overbaugh J.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):135-9. doi: 10.1097/QAI.0000000000000104.

25.

Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry.

Horowitz A, Strauss-Albee DM, Leipold M, Kubo J, Nemat-Gorgani N, Dogan OC, Dekker CL, Mackey S, Maecker H, Swan GE, Davis MM, Norman PJ, Guethlein LA, Desai M, Parham P, Blish CA.

Sci Transl Med. 2013 Oct 23;5(208):208ra145. doi: 10.1126/scitranslmed.3006702.

26.

The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life.

Slyker JA, Lohman-Payne B, John-Stewart GC, Dong T, Mbori-Ngacha D, Tapia K, Atzberger A, Taylor S, Rowland-Jones SL, Blish CA.

Front Immunol. 2012 Dec 31;3:399. doi: 10.3389/fimmu.2012.00399. eCollection 2012.

27.

HIV-1 transmission goes retro (steps back).

Blish CA.

J Infect Dis. 2012 Nov;206(9):1336-8. doi: 10.1093/infdis/jis506. Epub 2012 Sep 19. No abstract available.

PMID:
22997234
28.

Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.

Blish CA, McClelland RS, Richardson BA, Jaoko W, Mandaliya K, Baeten JM, Overbaugh J.

J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):436-40. doi: 10.1097/QAI.0b013e31826c2edd.

29.

Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study.

Blish CA, Dogan OC, Jaoko W, McClelland RS, Mandaliya K, Odem-Davis KS, Richardsonb BA, Overbaugh J.

AIDS. 2012 Mar 13;26(5):643-6. doi: 10.1097/QAD.0b013e3283509a0b.

30.

The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralization.

Lovelace E, Xu H, Blish CA, Strong R, Overbaugh J.

Virology. 2011 Dec 20;421(2):235-44. doi: 10.1016/j.virol.2011.09.032. Epub 2011 Oct 24.

31.

The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection.

Lynch JB, Nduati R, Blish CA, Richardson BA, Mabuka JM, Jalalian-Lechak Z, John-Stewart G, Overbaugh J.

J Virol. 2011 Jun;85(11):5252-61. doi: 10.1128/JVI.02216-10. Epub 2011 Mar 16.

32.

Hormonal contraception and HIV-1 transmission.

Blish CA, Baeten JM.

Am J Reprod Immunol. 2011 Mar;65(3):302-7. doi: 10.1111/j.1600-0897.2010.00930.x. Epub 2010 Nov 19. Review.

33.

Changes in plasma cytokines after treatment of ascaris lumbricoides infection in individuals with HIV-1 infection.

Blish CA, Sangaré L, Herrin BR, Richardson BA, John-Stewart G, Walson JL.

J Infect Dis. 2010 Jun 15;201(12):1816-21. doi: 10.1086/652784.

34.

Comparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopes.

Blish CA, Sather DN, Sellhorn G, Stamatatos L, Sun Y, Srivastava I, Barnett SW, Cleveland B, Overbaugh J, Hu SL.

J Virol. 2010 Mar;84(5):2573-84. doi: 10.1128/JVI.01687-09. Epub 2009 Dec 16.

35.

Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.

Piantadosi A, Panteleeff D, Blish CA, Baeten JM, Jaoko W, McClelland RS, Overbaugh J.

J Virol. 2009 Oct;83(19):10269-74. doi: 10.1128/JVI.01149-09. Epub 2009 Jul 29.

36.

Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1.

Blish CA, Jalalian-Lechak Z, Rainwater S, Nguyen MA, Dogan OC, Overbaugh J.

J Virol. 2009 Aug;83(15):7783-8. doi: 10.1128/JVI.00673-09. Epub 2009 May 27.

37.

Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.

Blish CA, Dogan OC, Derby NR, Nguyen MA, Chohan B, Richardson BA, Overbaugh J.

J Virol. 2008 Dec;82(24):12094-103. doi: 10.1128/JVI.01730-08. Epub 2008 Oct 8.

38.

Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.

Blish CA, Nguyen MA, Overbaugh J.

PLoS Med. 2008 Jan 3;5(1):e9. doi: 10.1371/journal.pmed.0050009.

39.

Transmission of HIV-1 in the face of neutralizing antibodies.

Blish CA, Blay WM, Haigwood NL, Overbaugh J.

Curr HIV Res. 2007 Nov;5(6):578-87. Review.

PMID:
18045114
40.

HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.

Blish CA, Nedellec R, Mandaliya K, Mosier DE, Overbaugh J.

AIDS. 2007 Mar 30;21(6):693-702.

PMID:
17413690
41.

Anergic CD8+ T cells can persist and function in vivo.

Blish CA, Dillon SR, Farr AG, Fink PJ.

J Immunol. 1999 Jul 1;163(1):155-64.

42.

Chronic modulation of the TCR repertoire in the lymphoid periphery.

Blish CA, Gallay BJ, Turk GL, Kline KM, Wheat W, Fink PJ.

J Immunol. 1999 Mar 15;162(6):3131-40.

Supplemental Content

Loading ...
Support Center